Skip to content

A Clinical Trial Into the Efficacy of rTMS Treatment for Treating Anorexia Nervosa and Bulimia Nervosa

A Clinical Trial Into the Efficacy of rTMS Treatment for Treating Anorexia Nervosa and Bulimia Nervosa

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04061304
Enrollment
0
Registered
2019-08-19
Start date
2020-06-01
Completion date
2021-03-19
Last updated
2021-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa, Bulimia Nervosa, Eating Disorders

Keywords

rTMS

Brief summary

This is a pilot study to test the efficacy of repetitive transcranial magnetic stimulation (rTMS) in treating individuals with Anorexia Nervosa and Bulimia Nervosa. The main objective of this study is to determine the short and long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in reducing eating disorder symptoms (i.e. binging, purging, restricting, intense fear of gaining wait, etc;) in Anorexia Nervosa and Bulimia Nervosa. The investigators will also be comparing the brain activity patterns of individuals with Anorexia Nervosa and Bulimia Nervosa to healthy controls using electroencephalography (EEG). Further, the investigators would like to examine if the activation patterns in these patients change after receiving rTMS.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

A non-invasive method of brain stimulation.

DEVICESham Transcranial Magnetic Stimulation

A device designed to look, sound, and feel like a real magnetic stimulation coil without actually stimulating the brain.

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Confirmed diagnosis of Anorexia Nervosa or Bulimia Nervosa, must pass rTMS screening questionnaire

Exclusion criteria

* Diagnosis of another psychiatric disorder, except MDD. * Any rTMS counter-indications: * History of seizures * Metal in head * Currently pregnant * Having received rTMS for any reason in the past as this would interfere with participant blinding.

Design outcomes

Primary

MeasureTime frameDescription
Weekly Binge/Purge Frequency on Eating Disorder Examinationbaseline, after week 1, week 2, and week 3 of treatment, 3 months post treatment, and 6 months post treatment.Outcome measured by change of binge/purge episodes from baseline to the end of treatment. If the participant has a final score of 0 binges and 0 purges they will be considered in remission. A 50% improvement will be defined as a response to the rTMS.

Secondary

MeasureTime frameDescription
Change in Beck Anxiety Inventory (BAI)baseline, after week 1, week 2, and week 3 of treatment, 3 months post treatment, and 6 months post treatment.Outcome range: 0-63, with higher scores reflecting higher levels of anxiety. A total of 21 questions are summed for a total score out of 63.
Change in Beck Depression Inventory (BDI)baseline, after week 1, week 2, and week 3 of treatment, 3 months post treatment, and 6 months post treatment.Outcome range: 0-63, with higher scores reflecting higher levels of depression. A total of 21 questions are summed for a total score out of 63.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026